CAS 81403-80-7

Alfuzosin

Description:

Alfuzosin is a medication primarily used to treat benign prostatic hyperplasia (BPH) in men, functioning as an alpha-1 adrenergic antagonist. Its mechanism of action involves relaxing the muscles in the prostate and bladder neck, which helps improve urine flow and reduce symptoms associated with BPH. Chemically, alfuzosin is characterized by its structure, which includes a quinazoline core, contributing to its pharmacological properties. It is typically administered orally and has a relatively long half-life, allowing for once-daily dosing. The substance is known for its selectivity towards the alpha-1A adrenergic receptor, which is predominantly found in the prostate, minimizing cardiovascular side effects commonly associated with non-selective alpha blockers. Alfuzosin is generally well-tolerated, but potential side effects may include dizziness, fatigue, and hypotension. As with any medication, it is essential for patients to consult healthcare professionals for appropriate usage and to discuss any potential interactions with other medications.

Formula: C₁₉H₂₇N₅O₄

InChI: InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)

InChI key: InChIKey=WNMJYKCGWZFFKR-UHFFFAOYSA-N

SMILES: NC=1C2=C(N=C(N(CCCNC(=O)C3CCCO3)C)N1)C=C(OC)C(OC)=C2

Synonyms:

• 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-
• 2-furancarboxamide, N-[3-[(5-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-
• N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide
• N-[3-[(5-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide
• N-[3-[N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-(methyl)amino]propyl]tetrahydrofuran-2-carboxamide
• N-{3-[(5-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
• Sl 77499
• Alfuzosin

N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide

CAS: 81403-80-7

Formula: C₁₉H₂₇N₅O₄

Purity: 99%

Color and Shape: Solid

Molecular weight: 389.4488

Ref: IN-DA00IKK8

Alfuzosin

CAS: 81403-80-7

Alfuzosin

Purity: ≥98%

Molecular weight: 389.45g/mol

Ref: 54-BUP11128

Alfuzosin

CAS: 81403-80-7

Formula: C₁₉H₂₇N₅O₄

Molecular weight: 389.45

Ref: 7W-GP4535

Alfuzosin-13C-d3

CAS: 81403-80-7

Formula: C₁₈₁₃CH₂₄D₃N₅O₄

Color and Shape: White To Off-White Solid

Molecular weight: 393.47

Ref: 4Z-A-9412

Alfuzosin

CAS: 81403-80-7

Alfuzosin (SL 77499) is an alpha-1 adrenergic antagonist used to treat benign prostatic hypertrophy and urethral dysfunction.

Formula: C₁₉H₂₇N₅O₄

Purity: 99.64%

Color and Shape: White Crystaline Powder

Molecular weight: 389.45

Ref: TM-T22232

Alfuzosin

CAS: 81403-80-7

Applications Alfuzosin (CAS# 81403-80-7) is a useful research chemical compound.

Formula: C₁₉H₂₈ClN₅O₄

Color and Shape: Neat

Molecular weight: 425.91

Ref: TR-A215435

Alfuzosin

CAS: 81403-80-7

?-adrenoceptor antagonist; treatment for benign prostatic hyperplasia

Formula: C₁₉H₂₇N₅O₄

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 389.45 g/mol

Ref: 3D-FA64935

Alfuzosin - Bio-X ™

CAS: 81403-80-7

Alfuzosin is an alpha-1 adrenoreceptor antagonist drug that is used in treatment and management of benign prostatic hyperplasia. This drug works by relaxing the muscles in the prostate and bladder neck which results in symptom improvement.

Formula: C₁₉H₂₇N₅O₄

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 389.45 g/mol

Ref: 3D-BA164145